Want to see IN:AARTIPHARM full AI Analyst Report?
Aarti Pharmalabs Limited (AARTIPHARM) Ratios
Aarti Pharmalabs Limited Ratios
IN:AARTIPHARM's free cash flow for Q1 2027 was $0.00. For the 2027 fiscal year, IN:AARTIPHARM's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.49 | 2.01 | 1.94 | 1.94 | 1.77 |
| Quick Ratio | 0.81 | 1.12 | 1.01 | 0.93 | 0.95 |
| Cash Ratio | 0.01 | 0.01 | 0.03 | 0.02 | 0.14 |
| Solvency Ratio | 0.21 | 0.39 | 0.35 | 0.37 | 0.25 |
| Operating Cash Flow Ratio | 0.28 | 0.50 | 0.31 | 0.42 | -0.08 |
| Short-Term Operating Cash Flow Coverage | 0.52 | 1.13 | 0.82 | 1.17 | -0.13 |
| Net Current Asset Value | $ 401.91M | $ 4.06B | $ 5.21B | $ 4.77B | $ 3.75B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.22 | 0.14 | 0.11 | 0.10 | 0.17 |
| Debt-to-Equity Ratio | 0.36 | 0.21 | 0.16 | 0.14 | 0.25 |
| Debt-to-Capital Ratio | 0.26 | 0.17 | 0.14 | 0.12 | 0.20 |
| Long-Term Debt-to-Capital Ratio | 0.08 | 0.05 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.64 | 1.46 | 1.47 | 1.44 | 1.47 |
| Debt Service Coverage Ratio | 0.60 | 1.21 | 1.09 | 1.18 | 0.47 |
| Interest Coverage Ratio | 6.36 | 14.03 | 16.35 | 13.28 | 13.78 |
| Debt to Market Cap | 0.12 | 0.06 | 0.06 | 0.09 | 0.13 |
| Interest Debt Per Share | 88.38 | 48.52 | 33.37 | 26.08 | 38.99 |
| Net Debt to EBITDA | 1.94 | 0.86 | 0.67 | 0.59 | 1.30 |
| Profitability Margins | |||||
| Gross Profit Margin | 54.12% | 46.67% | 21.53% | 21.28% | 26.20% |
| EBIT Margin | 15.38% | 18.32% | 17.50% | 14.49% | 13.06% |
| EBITDA Margin | 21.11% | 22.43% | 21.53% | 17.70% | 16.60% |
| Operating Profit Margin | 16.38% | 17.85% | 15.50% | 14.37% | 13.83% |
| Pretax Profit Margin | 12.80% | 17.05% | 16.55% | 13.41% | 13.03% |
| Net Profit Margin | 9.60% | 12.88% | 11.95% | 9.95% | 10.26% |
| Continuous Operations Profit Margin | 9.60% | 12.88% | 11.95% | 9.95% | 10.26% |
| Net Income Per EBT | 75.01% | 75.52% | 72.18% | 74.20% | 78.68% |
| EBT Per EBIT | 78.14% | 95.56% | 106.75% | 93.30% | 94.27% |
| Return on Assets (ROA) | 5.02% | 9.37% | 8.40% | 8.62% | 5.99% |
| Return on Equity (ROE) | 8.22% | 13.69% | 12.34% | 12.42% | 8.82% |
| Return on Capital Employed (ROCE) | 11.72% | 16.78% | 14.91% | 17.01% | 11.30% |
| Return on Invested Capital (ROIC) | 7.31% | 11.19% | 9.42% | 11.16% | 7.21% |
| Return on Tangible Assets | 5.20% | 9.71% | 8.66% | 8.79% | 6.06% |
| Earnings Yield | 3.03% | 3.99% | 5.33% | 7.74% | 4.68% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.12 | 3.64 | 3.42 | 4.26 | 3.06 |
| Payables Turnover | 2.50 | 4.06 | 3.77 | 4.51 | 4.10 |
| Inventory Turnover | 1.30 | 1.92 | 2.22 | 2.54 | 1.85 |
| Fixed Asset Turnover | 1.07 | 1.50 | 1.64 | 1.97 | 1.26 |
| Asset Turnover | 0.52 | 0.73 | 0.70 | 0.87 | 0.58 |
| Working Capital Turnover Ratio | 3.24 | 3.21 | 2.99 | 3.85 | 5.33 |
| Cash Conversion Cycle | 250.81 | 200.64 | 174.62 | 148.28 | 227.45 |
| Days of Sales Outstanding | 117.12 | 100.40 | 106.85 | 85.70 | 119.21 |
| Days of Inventory Outstanding | 279.95 | 190.15 | 164.70 | 143.50 | 197.27 |
| Days of Payables Outstanding | 146.27 | 89.91 | 96.92 | 80.92 | 89.04 |
| Operating Cycle | 397.07 | 290.55 | 271.54 | 229.20 | 316.49 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 28.89 | 36.56 | 23.87 | 27.60 | -4.82 |
| Free Cash Flow Per Share | -20.56 | -7.77 | 1.94 | 14.40 | -20.40 |
| Dividend Paid and CapEx Coverage Ratio | 0.54 | 0.76 | 1.00 | 1.82 | -0.31 |
| Capital Expenditure Coverage Ratio | 0.58 | 0.82 | 1.09 | 2.09 | -0.31 |
| Operating Cash Flow Coverage Ratio | 0.35 | 0.80 | 0.76 | 1.16 | -0.13 |
| Operating Cash Flow to Sales Ratio | 0.14 | 0.16 | 0.12 | 0.13 | -0.04 |
| Free Cash Flow Yield | -3.24% | -1.03% | 0.43% | 5.22% | -7.08% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 32.96 | 25.07 | 18.75 | 12.92 | 21.37 |
| Price-to-Sales (P/S) Ratio | 3.16 | 3.23 | 2.24 | 1.29 | 2.19 |
| Price-to-Book (P/B) Ratio | 2.71 | 3.43 | 2.31 | 1.60 | 1.88 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -30.89 | -96.96 | 231.51 | 19.16 | -14.13 |
| Price-to-Operating Cash Flow Ratio | 21.98 | 20.61 | 18.80 | 10.00 | -59.77 |
| Price-to-Earnings Growth (PEG) Ratio | -0.92 | 0.98 | 1.55 | 0.22 | -0.00 |
| Enterprise Value Multiple | 16.93 | 15.26 | 11.07 | 7.85 | 14.51 |
| Enterprise Value | 65.02B | 72.40B | 43.29B | 27.03B | 28.70B |
| EV to EBITDA | 16.93 | 15.26 | 11.07 | 7.85 | 14.51 |
| EV to Sales | 3.57 | 3.42 | 2.38 | 1.39 | 2.41 |
| EV to Free Cash Flow | -34.89 | -102.73 | 246.40 | 20.72 | -15.53 |
| EV to Operating Cash Flow | 24.82 | 21.84 | 20.01 | 10.81 | -65.68 |
| Tangible Book Value Per Share | 220.68 | 208.39 | 185.35 | 167.38 | 150.32 |
| Shareholders’ Equity Per Share | 234.34 | 219.44 | 193.85 | 171.97 | 152.99 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.25 | 0.24 | 0.28 | 0.26 | 0.21 |
| Revenue Per Share | 200.68 | 233.24 | 200.30 | 214.64 | 131.53 |
| Net Income Per Share | 19.27 | 30.04 | 23.93 | 21.35 | 13.49 |
| Tax Burden | 0.75 | 0.76 | 0.72 | 0.74 | 0.79 |
| Interest Burden | 0.83 | 0.93 | 0.95 | 0.93 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.02 | 0.00 | 0.01 | 0.01 |
| SG&A to Revenue | 0.22 | 0.08 | 0.01 | 0.01 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.15 | 1.22 | 1.00 | 0.96 | -0.28 |
Currency in INR